IRLAB Therapeutics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Kristina Torfgard
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | 12.1yrs |
Board average tenure | 2.8yrs |
Recent management updates
Recent updates
Is IRLAB Therapeutics (STO:IRLAB A) Using Debt Sensibly?
Oct 30IRLAB Therapeutics (STO:IRLAB A) Has Debt But No Earnings; Should You Worry?
Jun 06Here's Why We're Watching IRLAB Therapeutics' (STO:IRLAB A) Cash Burn Situation
Jan 04Here's Why IRLAB Therapeutics (STO:IRLAB A) Must Use Its Cash Wisely
Sep 21We Think IRLAB Therapeutics (STO:IRLAB A) Needs To Drive Business Growth Carefully
Mar 18IRLAB Therapeutics (STO:IRLAB A) Is In A Good Position To Deliver On Growth Plans
Dec 01We Like IRLAB Therapeutics' (STO:IRLAB A) Earnings For More Than Just Statutory Profit
May 19We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow
Sep 11We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow
Apr 30What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?
Mar 19We Think IRLAB Therapeutics (STO:IRLAB A) Can Afford To Drive Business Growth
Jan 25Our View On IRLAB Therapeutics' (STO:IRLAB A) CEO Pay
Dec 21What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?
Nov 25CEO
Kristina Torfgard (61 yo)
less than a year
Tenure
Dr. Kristina Torfgard, Ph.D. is Chief Executive Officer of IRLAB Therapeutics AB (publ) from August 1, 2024. Dr. Torfgard served as Vice President & Global Project Head at Albireo AB. Dr. Torfgard served a...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | less than a year | no data | no data | |
Chief Financial Officer | 8.1yrs | no data | 0.46% SEK 3.7m | |
Chief Scientific Officer | 12.1yrs | no data | 1.46% SEK 11.6m | |
Chief Information Officer and Director of Computational Chemistry & Biology | 12.1yrs | no data | 0.50% SEK 4.0m | |
Global IR & Communications | no data | no data | no data | |
Head of Finance & Human Resource and Director of Accounting & Human Resources | 12.1yrs | no data | no data | |
Executive VP and Head of R&D | no data | SEK 1.70m | 1.44% SEK 11.4m | |
Chief Medical Officer | 12.1yrs | SEK 5.00k | 1.22% SEK 9.7m |
12.1yrs
Average Tenure
62yo
Average Age
Experienced Management: IRLAB A's management team is seasoned and experienced (12.1 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Director | 9.1yrs | SEK 256.25k | 0.081% SEK 641.1k | |
Independent Chairman of the Board | 7.1yrs | SEK 400.00k | 0.027% SEK 214.2k | |
Director | 1.7yrs | SEK 147.50k | no data | |
Independent Director | 1.7yrs | SEK 160.00k | no data | |
Director | 8.1yrs | SEK 3.10m | 0.012% SEK 91.8k | |
Independent Director | 2.8yrs | SEK 264.17k | 0.015% SEK 122.4k | |
Director | 1.7yrs | SEK 175.00k | 8.71% SEK 69.2m |
2.8yrs
Average Tenure
62yo
Average Age
Experienced Board: IRLAB A's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/03 18:33 |
End of Day Share Price | 2025/02/03 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
IRLAB Therapeutics AB (publ) is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
null null | ABG Sundal Collier |
Gonzalo Artiach Castanon | ABG Sundal Collier Sponsored |
null null | ABG Sundal Collier Sponsored |